?Product Name?: 1-(3-Methoxyphenyl)piperazine Dihydrochloride (CAS 6968-76-9)
?Synonyms?: 1-(3-Methoxyphenyl)piperazine HCl; Letermovir Intermediate; m-Methoxyphenylpiperazine Dihydrochloride

?? ?Product Overview?

1-(3-Methoxyphenyl)piperazine Dihydrochloride is a high-purity pharmaceutical intermediate widely used in the synthesis of antiviral agents, including ?Letermovir?—a critical cytomegalovirus (CMV) prophylactic drug. Its unique structural properties make it essential for precise molecular modifications in API production and fine chemical R&D.

?Key Applications?:

• Antiviral drug synthesis (e.g., Letermovir)

• Pharmaceutical intermediates

• Fine chemical research

? ?Key Advantages?

?? ?High Purity?: ≥98% (HPLC/GC tested), ensuring reliable performance in sensitive reactions?2.
?? ?Stable Supply?: Produced by ?Shandong Chenghui Pharmaceutical Group? (established 2002, ISO-certified)?2.
?? ?Custom Packaging?: Available in 1kg to 25kg bulk quantities for flexible R&D and industrial use?2.

?? ?Applications?

• ?Antiviral Drug Development?: Key intermediate for Letermovir production?.

• ?Pharmaceutical Manufacturing?: Used in API synthesis for targeted therapies.

• ?Chemical Research?: Building block for novel organic compounds.

?? ?Quality & Compliance?

1. ?Certifications?: Complies with ISO 9001 and GMP standards?.

2. ?Testing?: Rigorous QC protocols including NMR, MS, and elemental analysis.

?? ?Market Insights?

The global antiviral drug market is projected to grow at a CAGR of 5.8% (2025-2030), driven by rising demand for CMV prophylaxis and precision therapeutics. Letermovir intermediates like this compound are pivotal in meeting pharmaceutical innovation needs.